Chardan Capital Markets reiterated a Buy rating on Medical Transcription Billing Corp (NASDAQ: MTBC ) Monday with a $6.25 price target. Analayst Keay Nakae noted that the company’s proprietary SaaS platform ...
from Content Keyword RSS http://ift.tt/1BHbeyv
via IFTTT
from Content Keyword RSS http://ift.tt/1BHbeyv
via IFTTT
No comments:
Post a Comment